Harmful and beneficial effects of anticoagulants in patients with cirrhosis and portal vein thrombosis V La Mura, S Braham, G Tosetti, F Branchi, N Bitto, M Moia, ... Clinical Gastroenterology and Hepatology 16 (7), 1146-1152. e4, 2018 | 102 | 2018 |
Coagulation, microenvironment and liver fibrosis N Bitto, E Liguori, VL Mura Cells 7 (8), 85, 2018 | 63 | 2018 |
Liver transplantation for porto-sinusoidal vascular liver disorder: long-term outcome M Magaz, H Giudicelli-Lett, O Nicoară-Farcău, N Rajoriya, A Goel, ... Transplantation 107 (6), 1330-1340, 2023 | 22 | 2023 |
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome M Magaz, H Giudicelli-Lett, JG Abraldes, O Nicoară-Farcău, F Turon, ... Journal of Hepatology 82 (1), 72-83, 2025 | 16* | 2025 |
Simvastatin prevents liver microthrombosis and sepsis induced coagulopathy in a rat model of endotoxemia V La Mura, N Gagliano, F Arnaboldi, P Sartori, P Procacci, L Denti, ... Cells 11 (7), 1148, 2022 | 15 | 2022 |
Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy V La Mura, N Bitto, C Capelli, C Caputo, S Siboni, S Arcudi, A Ciavarella, ... Blood Advances 7 (19), 5817-5824, 2023 | 8 | 2023 |
Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges V La Mura, N Bitto, A Tripodi Expert Review of Hematology 15 (12), 1031-1044, 2022 | 7 | 2022 |
Improving management of portal hypertension: The potential benefit of non-etiological therapies in cirrhosis N Bitto, G Ghigliazza, S Lavorato, C Caputo, V La Mura Journal of clinical medicine 12 (3), 934, 2023 | 6 | 2023 |
Coagulation and fibrosis: A potential non-negligible target of statins in chronic hepatitis N Bitto, F Salerno, A Tripodi, V La Mura Journal of Hepatology 63 (1), 277-278, 2015 | 5 | 2015 |
AB0, von Willebrand factor/factor VIII and portal vein thrombosis in decompensated cirrhosis: Too late to unmask the culprit? N Bitto, G Tosetti, V La Mura, M Primignani Liver International 40 (7), 1788-1789, 2020 | 3 | 2020 |
Clinical presentation and etiological spectrum of idiopathic non-cirrhotic portal hypertension (INCPH): data from the Italian Registry M Primignani, G Tosetti, V La Mura, N Bitto, L Turco, M Bianchini, S Gioia, ... Digestive and Liver Disease 51, e49, 2019 | 1 | 2019 |
Non-neoplastic portal vein thrombosis in HCV cirrhosis: the weight of inflammation on a fragile hemostatic balance N Bitto, V La Mura AME Medical Journal 2 (10), 2017 | 1 | 2017 |
Gene therapy in hemophilia: the dawn of a new era R Gualtierotti, A Giachi, N Bitto, V La Mura, F Peyvandi Research and Practice in Thrombosis and Haemostasis, 102640, 2024 | | 2024 |
OC 52.2 Residual Burden of Liver Disease After HCV-Clearance in Hemophilia: AWord of Caution in the Era of Gene Therapy V La Mura, N Bitto, C Capelli, C Caputo, S Siboni, S Arcudi, A Ciavarella, ... Research and Practice in Thrombosis and Haemostasis 7, 2023 | | 2023 |
Is non-alcoholic fatty liver disease a prothrombotic risk factor? N Bitto, V La Mura, AL Fracanzani, A Tripodi Bleeding, Thrombosis and Vascular Biology 2 (2), 2023 | | 2023 |
Liver health in patients with hemophilia: Residual risk factors of liver-related complications after HCV-clearance V La Mura, N Bitto, C Capelli, C Caputo, S Siboni, S Arcudi, A Ciavarella, ... Digestive and Liver Disease 55, S65-S66, 2023 | | 2023 |
Liver Health in Patients with Hemophilia: Residual Risk Factors of Liver-Related Complications after HCV Clearance V La Mura, N Bitto, C Capelli, SM Siboni, S Arcudi, A Ciavarella, ... Blood 140 (Supplement 1), 8440-8441, 2022 | | 2022 |
Factor VIII/protein C and not ADAMTS13/VWF: Ag ratio is a prognostic risk factor for patients with cirrhosis and low MELD score N Bitto, G Tosetti, A Tripodi, I Mancini, L Baronciani, C Valsecchi, ... Digestive and Liver Disease 52, e13-e14, 2020 | | 2020 |
ANTITHROMBOTIC PROPERTIES OF SIMVASTATIN ON THE ENDOTHELIUM AND PREVENTION OF LIVER MICROTHROMBOSIS AFTER EXPOSURE TO LIPOPOLYSACCHARIDE V La Mura, N Gagliano, F Arnaboldi, P Sartori, P Procacci, E Liguori, ... HEPATOLOGY 70, 69A-69A, 2019 | | 2019 |
Impact of von Willebrand factor and ADAMTS-13 on the pro-coagulant imbalance of patients with cirrhosis V La Mura, A Tripodi, N Bitto, G Tosetti, V Chantarangkul, L Baronciani, ... Digestive and Liver Disease 49 (1), e34, 2017 | | 2017 |